Hjem › Myeloproliferative neoplasmer › Illinois › Springfield
Kliniske studier for Myeloproliferative neoplasmer i Springfield, IL
3 studier for Myeloproliferative neoplasmer søker deltakere på steder i og rundt Springfield (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Saint John's Hospital, Springfield
- Southern Illinois University School of Medicine, Springfield
Myeloproliferative neoplasmer-studier i andre byer
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Chicago, IL9 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Atlanta, GA8 studier
- Tampa, FL8 studier
- Birmingham, AL8 studier
Andre studier i Springfield
- Ikke-småcellet lungekreft13 studier
- Lungekreft12 studier
- Kolorektal kreft9 studier
- Akut myelogen leukemi8 studier
- Brystkreft8 studier
- Plateepitelcancer i hode og hals6 studier
- Nyrekreft (nyrecellekarcinom)6 studier
- Prostatakreft6 studier
- Kreft (alle typer)6 studier
- Blærekreft6 studier
- Pankreaskreft5 studier
- Melanom5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.